3-6, January ,2018 , which is newly established in Farmatek Dermatology team made launches of Alocort,Topiclin and Benzoxin Read More
The decision to switch to the SAP system, which is well-known, widely supported in the industry and appropriate to pharmaceutical standards, was made in June 2016.Read More
Our R&D Center, established at the heart of our plant whose foundations were laid on 29.05.2014, was accredited by the Ministry of Science, Industry and Technology, exactly three years later, on 29.05.2017. Being one of the 85 pharmaceutical companies manufacturing in Turkey, our R&D Center is ranked in the 24th place.Read More
“In line with our strategical objective of acutely presence in international markets, Farma-Tek has participated in SAPHEX 2017 international exhibition which was held on 28-29th of November 2017 in Johannesburg.Read More
Pharmaceutical Technology Laboratory established within the R&D Center at our manufacturing plant was issued the GMP certificate following an inspection performed by the Ministry of Health and was registered as the first and only GMP-Certified Pharmaceutical Technology Laboratory as of March 2017.
We are anchoring hematology.
Participated in the 43rd National Hematology Congress with 1 unit stand.Read More
Farmatek NephroVirology group launched 3 new products in a meeting held in Istanbul on 16-19 June 2017. Medical trainings for Viratit tablets containing entecavir and Nefovir tablet containing tenofovir used in Hepatitis-B treatment and Citovir tablets used for cytomegalovirus treatment were given by Ayşe Köse, MD.Read More
Talaseme Federation meeting was held between 28-29 October 2017. FARMATEK was invited by Burhan Kerimoğlu, president of the association. The meeting provided significant support to our awareness in the field of hematology.Read More
Farmatek Pharmaceuticals took part in the R&D Collaboration Summit and Fair organized by the Ministry of Development and the Ministry of Science, Industry and Technology on 3 – 5 May 2017 hosting many key players from a variety of industries including defense, telecommunications, transportation, and pharmaceuticals. We actively participated in an industry specific workshop with regulatory authorities while conducting one-to-one interviews for future strategic partnerships.
Our stand was visited by the Undersecretaries of the Ministry of Health and the Ministry of Development, and Chairman of TITCK.